Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells
about
CXCR2: a target for pancreatic cancer treatment?Ligand pose and orientational sampling in molecular dockingPUMA: a puzzle piece in chloroquine's antimelanoma activity.CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.CCR9-mediated signaling through β-catenin and identification of a novel CCR9 antagonist.Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer.Structural Analysis of Chemokine Receptor-Ligand Interactions.Small molecule inhibitors of CXCR4.Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.Chloroquine-Containing HPMA Copolymers as Polymeric Inhibitors of Cancer Cell Migration Mediated by the CXCR4/SDF-1 Chemokine Axis.Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based studyChloroquine-Modified Hydroxyethyl Starch as a Polymeric Drug for Cancer Therapy.MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.Synthesis and Evaluation of Chloroquine-Containing DMAEMA Copolymers as Efficient Anti-miRNA Delivery Vectors with Improved Endosomal Escape and Antimigratory Activity in Cancer Cells.Polymeric chloroquine as an inhibitor of cancer cell migration and experimental lung metastasis.Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model.Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents.Effect of hydroxychloroquine on oxidative/nitrosative status and angiogenesis in endothelial cells under high glucose condition.
P2860
Q27021588-E512A317-CE85-4F35-A71F-75A803A16298Q28533958-A1F93C44-F3C9-48DC-BD6D-C539CA5A1175Q33356363-1FD1F42B-D5C1-4B03-B9D2-C4F094724599Q33677057-76A12000-2546-44EE-9C28-468F855FEA12Q33907480-73AAA89F-501A-4839-A094-CF263947FE66Q34179827-439903C3-43B6-4193-A5A7-C50A8DA3FB97Q34550666-CBD0F3C6-3996-44D3-ABD8-32EA47D6DF49Q34574987-1EF430CE-0FC7-444F-96AC-EB76E021C5ABQ35739397-C92CA907-7FC8-4F25-9C58-879776B91F5AQ37375733-EA7BF224-33FC-4DBA-B447-AFDC4792D4F0Q37430032-28FEBE01-548E-4D4F-9AFC-7815340A07EBQ38657644-DBF137D8-3335-42E6-9E63-F5E1EF483030Q39014048-F120CB1A-62F9-4B7C-AD36-B4D3D6D914EFQ41912199-622A77F2-7C7C-4549-8262-64E4A0F07112Q41914534-D0CEB4FE-2AE0-4D56-A725-31EBB93A82C9Q43194438-B4C13D00-BA00-4E2A-8832-AEAFFD0B1F64Q47162451-5DEFB26B-E3DE-489C-B8ED-D371EB2CAE0BQ49737696-733F95CC-3131-40A0-8368-34BCD5A2C52A
P2860
Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Identification of anti-malaria ...... CR4 in pancreatic cancer cells
@ast
Identification of anti-malaria ...... CR4 in pancreatic cancer cells
@en
Identification of anti-malaria ...... CR4 in pancreatic cancer cells
@nl
type
label
Identification of anti-malaria ...... CR4 in pancreatic cancer cells
@ast
Identification of anti-malaria ...... CR4 in pancreatic cancer cells
@en
Identification of anti-malaria ...... CR4 in pancreatic cancer cells
@nl
prefLabel
Identification of anti-malaria ...... CR4 in pancreatic cancer cells
@ast
Identification of anti-malaria ...... CR4 in pancreatic cancer cells
@en
Identification of anti-malaria ...... CR4 in pancreatic cancer cells
@nl
P2093
P2860
P3181
P1433
P1476
Identification of anti-malaria ...... CR4 in pancreatic cancer cells
@en
P2093
Eileen L Heinrich
Jianming Lu
Joseph Kim
Li-Yu Charlie Hsin
M L Richard Yip
Nagarajan Vaidehi
Samuel Labarge
Xiaoming Shen
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0031004
P407
P577
2012-01-01T00:00:00Z